LOS ANGELES, Feb 22 (Reuters)—Biotechnology company Advanced Cell Technology Inc. (ACTC.OB) plans to publish in the first half of this year data from trials in animals of its stem cell-based therapies for macular degeneration, Chief Executive William Caldwell said on Wednesday…(Read More)
Reuters
http://yahoo.reuters.com